Safranal, an active ingredient of saffron, attenuates cognitive deficits in amyloid β-induced rat model of Alzheimer’s disease: underlying mechanisms

被引:0
|
作者
Tourandokht Baluchnejadmojarad
Seyed-Mahdi Mohamadi-Zarch
Mehrdad Roghani
机构
[1] Iran University of Medical Sciences,Department of Physiology, School of Medicine
[2] Shahed University,Neurophysiology Research Center
来源
Metabolic Brain Disease | 2019年 / 34卷
关键词
Alzheimer’s disease; Amyloid β; Safranal; Learning and memory; Oxidative stress; Inflammation;
D O I
暂无
中图分类号
学科分类号
摘要
Alzheimer’s disease (AD) is the most prevalent neurodegenerative amyloid disorder with progressive deterioration of cognitive and memory skills. Despite many efforts, no decisive therapy yet exists for AD. Safranal is the active constituent of saffron essential oil with antioxidant, anti-inflammatory, and anti-apoptotic properties. In this study, the possible beneficial effect of safranal on cognitive deficits was evaluated in a rat model of AD induced by intrahippocampal amyloid beta (Aβ1–40). Safranal was daily given p.o. (0.025, 0.1, and 0.2 ml/kg) post-surgery for 1 week and finally learning and memory were evaluated in addition to assessment of the involvement of oxidative stress, inflammation, and apoptosis. Findings showed that safranal treatment of amyloid β-microinjected rats dose-dependently improved cognition in Y-maze, novel-object discrimination, passive avoidance, and 8-arm radial arm maze tasks. Besides, safranal attenuated hippocampal level of malondialdehyde (MDA), reactive oxygen species (ROS), protein carbonyl, interleukin 1β (IL-1β), interleukin 6 (IL-6), tumor necrosis factor α (TNFα), nuclear factor-kappa B (NF-kB), apoptotic biomarkers including caspase 3 and DNA fragmentation, glial fibrillary acidic protein (GFAP), myeloperoxidase (MPO), and acetylcholinesterase (AChE) activity and improved superoxide dismutase (SOD) activity and mitochondrial membrane potential (MMP) with no significant effect on nitrite, catalase activity, and glutathione (GSH). Furthermore, safranal prevented CA1 neuronal loss due to amyloid β1–40. In summary, safranal treatment of intrahippocampal amyloid beta1–40-microinjected rats could prevent learning and memory decline via neuronal protection and at a molecular level through amelioration of apoptosis, oxidative stress, inflammation, cholinesterase activity, neutrophil infiltration, and also by preservation of mitochondrial integrity.
引用
收藏
页码:1747 / 1759
页数:12
相关论文
共 50 条
  • [1] Safranal, an active ingredient of saffron, attenuates cognitive deficits in amyloid β-induced rat model of Alzheimer's disease: underlying mechanisms
    Baluchnejadmojarad, Tourandokht
    Mohamadi-Zarch, Seyed-Mahdi
    Roghani, Mehrdad
    METABOLIC BRAIN DISEASE, 2019, 34 (06) : 1747 - 1759
  • [2] Betaine attenuates oxidative stress and cognitive dysfunction in an amyloid β-induced rat model of Alzheimer's disease
    Alipourfard, Fatemeh
    Shajiee, Hooman
    Nazari-Serenjeh, Farzaneh
    Hojati, Vida
    Alirezaie, Masoud
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2023, 18 (03) : 270 - 278
  • [3] Ellagic acid ameliorates learning and memory deficits in a rat model of Alzheimer's disease: an exploration of underlying mechanisms
    Kiasalari, Zahra
    Heydarifard, Rana
    Khalili, Mohsen
    Afshin-Majd, Siamak
    Baluchnejadmojarad, Tourandokht
    Zahedi, Elham
    Sanaierad, Ashkan
    Roghani, Mehrdad
    PSYCHOPHARMACOLOGY, 2017, 234 (12) : 1841 - 1852
  • [4] Ellagic acid ameliorates learning and memory deficits in a rat model of Alzheimer’s disease: an exploration of underlying mechanisms
    Zahra Kiasalari
    Rana Heydarifard
    Mohsen Khalili
    Siamak Afshin-Majd
    Tourandokht Baluchnejadmojarad
    Elham Zahedi
    Ashkan Sanaierad
    Mehrdad Roghani
    Psychopharmacology, 2017, 234 : 1841 - 1852
  • [5] Scutellarin alleviates lipopolysaccharide-induced cognitive deficits in the rat: Insights into underlying mechanisms
    Baluchnejadmojarad, Tourandokht
    Zeinali, Hossein
    Roghani, Mehrdad
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 54 : 311 - 319
  • [6] Chitosan oligosaccharides alleviate cognitive deficits in an amyloid-β1-42-induced rat model of Alzheimer's disease
    Jia, Shiliang
    Lu, Zheng
    Gao, Zhaolan
    An, Jun
    Wu, Xueling
    Li, Xiaoxiao
    Dai, Xueling
    Zheng, Qiusheng
    Sun, Yaxuan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2016, 83 : 416 - 425
  • [7] Amelioration of Amyloid β-Induced Cognitive Deficits by Zataria multiflora Boiss. Essential Oil in a Rat Model of Alzheimer's Disease
    Majlessi, Nahid
    Choopani, Samira
    Kamalinejad, Mohammad
    Azizi, Zahra
    CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (04) : 295 - 301
  • [8] Edaravone injection ameliorates cognitive deficits in rat model of Alzheimer’s disease
    Rui Yang
    Qingjun Wang
    Fang Li
    Jian Li
    Xuewen Liu
    Neurological Sciences, 2015, 36 : 2067 - 2072
  • [9] Edaravone injection ameliorates cognitive deficits in rat model of Alzheimer's disease
    Yang, Rui
    Wang, Qingjun
    Li, Fang
    Li, Jian
    Liu, Xuewen
    NEUROLOGICAL SCIENCES, 2015, 36 (11) : 2067 - 2072
  • [10] β-Lapachone attenuates cognitive impairment and neuroinflammation in beta-amyloid induced mouse model of Alzheimer's disease
    Mokarizadeh, Narmin
    Karimi, Pouran
    Erfani, Marjan
    Sadigh-Eteghad, Saeed
    Maroufi, Nazila Fathi
    Rashtchizadeh, Nadereh
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 81